Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01398397 · ClinicalTrials.gov registry record
Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype
A clinical trial, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 11
- Enrollment target
NCT01398397 is a clinical trial that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 11 participants.
The verdict
NCT01398397 has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This study is being done to collect information about people who have or may have Hypohidrotic Ectodermal Dysplasia (HED) or X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). This study will allow Edimer Pharmaceuticals to know more about HED/XLHED so that hopefully the investigators can develop a drug to treat this condition. In this study Edimer will retrospectively review and abstract (summarize) medical records of people that have or may have HED/XLHED in order to further understand the natural history and disease characteristics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01398397
The ClinicalTrials.gov registry entry for NCT01398397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edimer Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01398397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01398397 about?
NCT01398397 is a clinical study titled "Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype". This study is being done to collect information about people who have or may have Hypohidrotic Ectodermal Dysplasia (HED) or X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). This study will allow Edimer Pharmaceuticals to know more about HED/XLHED so that hopefully the investigators can develop a...
What is the current status of trial NCT01398397?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2011-04.
Who is sponsoring clinical trial NCT01398397?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.